Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised,open-label,phase 3 trial |
| |
| Institution: | 1. Gynaecologic Oncology Center, Kiel, Germany;2. Oncology Department, Mater Cancer Care Centre, Brisbane, QLD, Australia;3. Gynaecology Department, Klinikum der Stadt Ludwigshafen am Rhein, Ludwigshafen, Germany;4. Coordinating Center for Clinical Trials, Philipps-University, Marburg, Germany;5. Department of Gynecology and Gynecological Oncology, Kliniken Essen-Mitte, Essen, Germany;6. Gynaecology Department, Centre François Baclesse, Caen, France;7. Department of Gynaecology, and European Competence Center for Ovarian Cancer, Charité – Universitätsmedizin Berlin, Campus Virchow, Berlin, Germany;8. Department of Gynaecology, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany;9. Technical University of Munich–Klinikum Rechts der Isar, Germany;10. Department of Gynaecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany;11. Gynaecological Oncology Department, St John of God Hospital, Subiaco, WA, Australia;12. Gynaecology Department, Erlangen University Hospital, Erlangen, Germany;13. Department of Obstetrics and Gynaecology, Innsbruck Medical University, Innsbruck, Austria;14. Gynaecology Department, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany;15. Paul Strauss Cancer Center and Gynaecology Department, University of Strasbourg, Strasbourg, France;p. Gynaecology Department, National Center for Tumor Disease, University of Heidelberg, Heidelberg, Germany;q. Department of Gynaecology and Obstetrics, University Hospital Mannheim, Mannheim, Germany;r. Department of Gynaecology and Obstetrics, University of Frankfurt/Main, Frankfurt, Germany;s. National Cancer Research Institute, Beatson West of Scotland Cancer Centre and University of Glasgow, Glasgow, UK;t. Department of Obstetrics and Gynaecology, University of Ulm, Ulm, Germany;u. Department of Obstetrics and Gynaecology, University Hospital, Ludwig-Maximilian-University, Munich, Germany;v. Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, WA, Australia;w. Department of Gynaecology and Obstetrics, Medical University Hannover, Hannover, Germany;x. Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France;y. Department of Oncology, Hôpital Michallon, Grenoble, France;z. Department of Gynaecology and Obstetrics, Evangelisches Krankenhaus Düsseldorf, Germany;11. Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Düsseldorf, Germany;12. Department of Gynecology and Gynecologic Oncology, Comprehensive Cancer Centre, University Hospital for Gynaecology, Medical University Vienna, Vienna, Austria;13. Royal Brisbane & Women''s Hospital, Brisbane, QLD, Australia;14. Centre Hospitalier Départemental les Oudairies, La Roche-Sur-Yon, France;15. Women''s Health, Royal North Shore Hospital, Sydney, NSW, Australia;16. Department of Women''s Health, Tübingen University Hospital, Tübingen, Germany;17. Haematology–Oncology Department, Centre Hospitalier Régional et Universitaire de Strasbourg Hôpital Civil, Strasbourg, France |
| |
| Abstract: | |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
